Viral Vector Manufacturing

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

Chris Berger; Kilian Witzel

Avid Bioservices

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

Damien Marsic, Ph.D.

Porton Advanced Solutions

Viral Vector Manufacturing

Optimizing Transient Transfection for Viral Vector Production

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

Elie Hanania, Ph.D.; Tatiana Mello, M.S.

Avid Bioservices

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

Viral Vector Manufacturing

Avid Bioservices, Inc. and CRB Highlight Efforts that Enabled Opening of First Phase of New Viral Vector Facility in California in Only Eight Months

Avid Bioservices, Inc.

Viral Vector Manufacturing

Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design

Chris Berger; Atef Khezri

Avid Bioservices

GMP Certification

GMP Certification for Exothera Further Extends its Viral Vector Manufacturing Capacity

Exothera

Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Andrew Moreo; Lenore Giannunzio

Andelyn Biosciences

Viral Vectors

Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

Heidi Trusheim, Ph.D.

IDT Biologika

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

Viral Vaccines

Viral Vectors, Vaccines — A New Era Of Collaborative Design

Andreas Neubert, Ph.D.

IDT Biologika

Cell and Gene Therapy

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

Cyrill Kellerhals; Sarah O'Reilly

Andelyn Biosciences

Gene Therapy

A Customer-Centric Approach to Cell and Gene Therapy Manufacturing

Drew Brennan

Avid Bioservices

Viral Vectors

Navigating Analytical Requirements for GMP Viral Vectors

Will Fountain

Andelyn Biosciences

Gene Therapy

Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing

Wade Macedone; Jonathan Rush; Phillip Vermilion; Samir Acharya, Ph.D.

Andelyn Biosciences

Gene Therapy

Pandemic Playbook for Gene Therapy Manufacturing

Ratish Krishnan; David Loong, Ph.D.; Nargisse El-Hajjami, Ph.D.

MilliporeSigma

Gene Therapy

Andelyn Biosciences: A New CDMO with Roots in Gene Therapy Research Set to Drive Key Manufacturing Advances

Wade Macedone; Mayo Pujols

Andelyn Biosciences

Cell and Gene Therapy

Expanding a Comprehensive Platform to Support the Future of Cell and Gene Therapies

David Y. H. Chang, Ph.D.

WuXi Advanced Therapies